| 上海医药 | 11Q2 | 11Q1 | 10Q4 | 10Q3 | 10Q2 | 10Q1 | 09Q4 | 09Q3 | 09Q2 | 09Q1 |
| 当季收盘价 | 16.83 | 19.55 | 21.84 | 22.35 | 16.38 | 15.36 | 16.83 | 0 | 0 | 0 |
| 赢利能力评分 | 34.22 | 46.98 | 52.38 | 94.14 | 94.17 | 94.21 | 50.21 | 52.08 | 82.66 | 28.55 |
| 成长能力评分 | 68.13 | 56.58 | 72.85 | 100.00 | 100.00 | 100.00 | 85.00 | 75.05 | 73.65 | 70.37 |
| 估值情况评分 | 62.71 | 61.42 | 58.75 | 74.01 | 83.06 | 88.06 | 61.42 | 数据为空 | 数据为空 | 数据为空 |
| 信用情况评分 | 74.91 | 75.84 | 71.32 | 87.88 | 93.94 | 94.72 | 75.92 | 76.03 | 79.30 | 78.31 |
| 综合情况评价 | 55.25 | 55.40 | 62.08 | 90.85 | 93.42 | 94.72 | 66.47 | 数据为空 | 数据为空 | 数据为空 |
| 报表期每股收益(元) | 0.48 | 0.43 | 0.69 | 0.55 | 0.38 | 0.20 | 0.66 | 0.23 | 0.12 | 0.07 |
| 预估全年每股收益(调整) | 0.48 | 0.60 | 0.60 | 2.18 | 2.10 | 4.05 | 0.48 | 0.62 | 1.38 | 0.28 |
| 每股净资产(元) | 9.43 | 6.29 | 5.96 | 5.91 | 5.66 | 5.61 | 5.23 | 3.96 | 3.82 | 3.78 |
| 每股自由现金流(元) | 0.26 | 0.15 | 0.82 | 0.45 | 0.55 | 0.17 | 0.61 | 0.85 | 0.89 | 0.47 |
| 当季净利润 | 4.55 | 8.49 | 2.63 | 3.39 | 3.74 | 3.92 | 11.80 | 0.61 | 0.28 | 0.43 |
| 当季主营业务收入 | 133.42 | 118.68 | 95.18 | 93.70 | 90.25 | 94.98 | 162.99 | 52.88 | 47.63 | 47.23 |
| 预估全年净利润(调整) | 12.99 | 11.95 | 11.91 | 43.37 | 41.94 | 80.61 | 9.61 | 3.50 | 7.86 | 1.61 |
| 预估全年主营业务收入 | 509.17 | 467.45 | 374.11 | 586.66 | 606.74 | 624.93 | 310.73 | 199.93 | 200.15 | 192.84 |
| 市净率 | 1.78 | 3.11 | 3.66 | 3.78 | 2.89 | 2.74 | 3.22 | 0.00 | 0.00 | 0.00 |
| 市销率(折算为全年数据) | 1.03 | 1.03 | 1.37 | 0.86 | 0.63 | 0.58 | 1.26 | 0.11 | 0.11 | 0.12 |
| 市盈率(调整) | 34.83 | 32.61 | 36.55 | 10.27 | 7.78 | 3.80 | 34.88 | 0.00 | 0.00 | 0.00 |
| 市盈率(含债去息税) | 34.54 | 36.34 | 35.59 | 10.71 | 8.38 | 4.22 | 33.09 | 4.43 | 2.20 | 10.47 |
| PER(以当期ROE为增长标准) | 6.74 | 3.92 | 3.50 | 0.37 | 0.29 | 0.10 | 3.46 | 0.31 | 0.08 | 1.48 |
| PEG(以3年均净利增长为标准) | 0.11 | 0.12 | 0.11 | 0.02 | 0.02 | 0.01 | 数据为空 | 数据为空 | 数据为空 | 数据为空 |
| PEG(以3年均收入增长为标准) | 0.72 | 0.82 | 0.84 | 0.16 | 0.12 | 0.06 | 0.85 | 0.27 | 0.13 | 0.69 |
| 预估总资产报酬率(调整) | 2.87% | 3.78% | 4.23% | 16.37% | 16.96% | 33.08% | 4.35% | 3.82% | 9.14% | 1.89% |
| 预估投入资本报酬率(调整) | 4.52% | 6.45% | 7.59% | 31.49% | 31.82% | 58.42% | 7.36% | 9.30% | 21.04% | 4.23% |
| 预估股东权益报酬率(调整) | 5.12% | 9.28% | 10.17% | 28.91% | 28.50% | 42.77% | 9.55% | 14.17% | 27.22% | 7.09% |
| 自由现金流与营业收入之比 | 2.81% | 2.59% | 4.34% | 3.23% | 5.96% | 3.48% | 3.94% | 3.28% | 5.35% | 5.71% |
| 二级市场自由现金收益率-报表期 | 1.44% | 0.60% | 3.04% | 1.67% | 2.74% | 0.86% | 3.04% | 8.67% | 9.97% | 5.27% |
| 总收入同比增长率 | 36.10% | 24.95% | 20.40% | 88.80% | 95.26% | 101.12% | 87.77% | 20.82% | 20.95% | 16.53% |
| 净利润同比增长率 | 70.11% | 116.57% | 4.38% | 745.61% | 992.28% | 820.67% | 1498.95% | 63.75% | 55.27% | 67.52% |
| 当季收入同比增长率 | 47.84% | 24.95% | -41.60% | 77.21% | 89.46% | 101.12% | 277.28% | 20.59% | 25.67% | 16.53% |
| 当季净利润同比增长率 | 21.47% | 116.57% | -77.70% | 459.89% | 1257.12% | 820.67% | 54198.27% | 74.81% | 39.52% | 67.52% |
| 当季净利润同比增长率(调整) | -155.68% | -23.98% | -69.54% | 386.05% | 185.24% | 738.39% | 1961.62% | 62.84% | 数据为空 | 73.19% |
| 非经常项占比 | 50.90% | 71.43% | 15.84% | 15.24% | 17.23% | 14.52% | 34.01% | -84.90% | -152.16% | 5.07% |
| 净利润率(还原) | 2.30% | 2.31% | 2.57% | 2.74% | 2.75% | 2.76% | 2.29% | 1.28% | 1.39% | 0.72% |
| 税前利润率(还原) | 3.75% | 4.18% | 4.48% | 4.84% | 4.71% | 4.58% | 4.44% | 2.38% | 2.57% | 1.64% |
| 主营业务利润率 | 14.41% | 15.36% | 17.88% | 18.03% | 18.37% | 18.44% | 18.82% | 8.55% | 8.57% | 8.37% |
| 当季净利润率(还原) | 2.30% | 2.31% | 2.06% | 2.72% | 2.74% | 2.76% | 3.20% | 1.09% | 2.05% | 0.72% |
| 当季税前利润率(还原) | 3.36% | 4.18% | 3.42% | 5.09% | 4.85% | 4.58% | 6.31% | 2.05% | 3.48% | 1.64% |
| 当季主营业务利润率 | 13.56% | 15.36% | 17.42% | 17.37% | 18.30% | 18.44% | 28.13% | 8.52% | 8.76% | 8.37% |
| 当季权益报酬率(调整) | -0.68% | 2.08% | 1.81% | 2.57% | 2.65% | 3.00% | 5.99% | 2.88% | 6.28% | 1.88% |
| 经营性现金流同比增长率 | -13.38% | -3.20% | -11.54% | 106.91% | 85.50% | 54.03% | 567.23% | 数据为空 | 8628.54% | 数据为空 |
| 综合业务利润率 | 14.41% | 15.36% | 17.88% | 18.03% | 18.37% | 18.44% | 18.82% | 8.55% | 8.57% | 8.37% |
| 当季综合业务利润率 | 13.56% | 15.36% | 17.42% | 17.37% | 18.30% | 18.44% | 28.13% | 8.52% | 8.76% | 8.37% |
| 总市值 | 452.54 | 389.56 | 435.19 | 445.36 | 326.39 | 306.07 | 335.36 | 0.00 | 0.00 | 0.00 |
| 总市值含债调整 | 499.07 | 457.36 | 484.04 | 478.97 | 359.31 | 342.61 | 369.52 | 0.00 | 0.00 | 0.00 |
| 资本性支出(亿) | 1.61 | 1.23 | 0.62 | 2.20 | (1.00) | 1.15 | 6.82 | 0.58 | 0.35 | 0.19 |
| 资本支出与销售收入比 | 0.64% | 1.04% | 0.16% | 0.79% | -0.54% | 1.21% | 2.19% | 0.39% | 0.36% | 0.41% |
| 总市值中的现金比例 | 35.45% | 16.29% | 14.56% | 12.15% | 17.57% | 17.50% | 14.57% | 数据为空 | 数据为空 | 数据为空 |
| 营业费用与收入之比 | 6.06% | 6.36% | 8.04% | 7.95% | 8.20% | 7.86% | 8.44% | 3.67% | 3.35% | 4.23% |
| 管理费用与收入之比 | 3.89% | 4.12% | 4.81% | 4.67% | 4.85% | 5.39% | 5.30% | 1.95% | 2.05% | 1.84% |
| 财务费用与收入之比 | 0.71% | 0.70% | 0.55% | 0.57% | 0.61% | 0.60% | 0.64% | 0.56% | 0.61% | 0.66% |
| 期间费用占收入比 | 10.66% | 11.18% | 13.40% | 13.19% | 13.66% | 13.85% | 14.38% | 6.17% | 6.00% | 6.74% |
| 当季期间费用占收入比 | 10.20% | 11.18% | 14.00% | 12.28% | 13.45% | 13.85% | 21.82% | 6.48% | 5.28% | 6.74% |
| 期间费用占收入比同比增长率 | -21.93% | -19.32% | -6.82% | 113.74% | 127.47% | 105.69% | 93.05% | -19.90% | -25.99% | -11.48% |
| 当季期间费用占收入比同比增长率 | -24.14% | -19.32% | -35.83% | 89.60% | 154.81% | 105.69% | 224.76% | -7.24% | -38.98% | -11.48% |
| 生息负债率 | 10.26% | 21.48% | 17.34% | 12.69% | 13.31% | 15.00% | 15.47% | 19.88% | 21.19% | 22.56% |
| 资产负债率 | 44.05% | 60.30% | 57.81% | 55.59% | 54.35% | 54.12% | 52.84% | 75.42% | 74.75% | 74.74% |
| 每股生息负债(元) | 1.73 | 3.40 | 2.45 | 1.69 | 1.65 | 1.83 | 1.71 | 3.20 | 3.20 | 3.38 |
| 免息负债与净资产比 | 0.60 | 0.98 | 0.96 | 0.97 | 0.90 | 0.85 | 0.79 | 2.26 | 2.12 | 2.07 |
| 生息负债与净资产比 | 0.18 | 0.54 | 0.41 | 0.29 | 0.29 | 0.33 | 0.33 | 0.81 | 0.84 | 0.89 |
| 每股现金保有额(元) | 5.97 | 3.18 | 3.18 | 2.72 | 2.88 | 2.69 | 2.45 | 2.32 | 2.36 | 2.21 |
| 存货环比增长率 | 36.32% | -5.27% | 14.87% | 14.05% | 9.29% | -5.22% | 117.33% | 7.95% | 0.82% | -3.23% |
| 应收帐款环比增长率 | 31.52% | 18.94% | -12.15% | 17.04% | 0.63% | 35.31% | 27.20% | 14.24% | 2.35% | 24.55% |
| 存货同比增长率 | 69.17% | 35.63% | 35.70% | 156.74% | 143.02% | 124.18% | 128.89% | 5.60% | -1.52% | 11.62% |
| 应收帐款同比增长率 | 60.83% | 23.05% | 39.99% | 102.71% | 97.87% | 101.25% | 85.24% | 27.30% | 18.54% | 12.63% |
| 预收帐款同比增长率 | 48.45% | 40.41% | 24.67% | 171.51% | 84.17% | 604.26% | 131.11% | 143.67% | 184.51% | -11.16% |
| 存货周转率 - 单期值 | 6.67 | 8.24 | 6.07 | 10.92 | 12.83 | 14.43 | 6.77 | 10.68 | 11.54 | 11.23 |
| 总资产周转率-单期值 | 1.12 | 1.48 | 1.33 | 2.21 | 2.45 | 2.56 | 1.41 | 2.18 | 2.33 | 2.26 |
| 净资产周转率-单期值 | 2.01 | 3.73 | 3.15 | 4.99 | 5.38 | 5.59 | 2.98 | 8.88 | 9.22 | 8.95 |
| 应收帐款周转率--单期值 | 5.61 | 6.77 | 6.44 | 8.87 | 10.74 | 11.13 | 7.49 | 6.13 | 7.01 | 6.91 |
| 流动资产周转率--单期值 | 1.75 | 2.11 | 1.89 | 3.24 | 3.57 | 3.99 | 2.87 | 2.96 | 3.13 | 3.26 |
| 固定资产周转率--单期值 | 14.58 | 13.36 | 10.26 | 17.15 | 18.25 | 17.60 | 8.62 | 24.06 | 24.15 | 23.14 |
| 股本同比变动率 | 34.94% | 0.00% | 0.00% | 250.09% | 250.09% | 250.09% | 250.09% | 0.00% | 0.00% | 0.00% |
| 税前利润同比增长率 | 55.61% | 110.51% | 1.22% | 542.06% | 629.64% | 561.97% | 1049.55% | 60.19% | 55.61% | 77.46% |
| 每股营运资金(元) | 5.72 | 2.50 | 2.40 | 2.30 | 2.08 | 1.95 | 1.66 | 0.35 | 0.22 | 0.01 |
| 短期借款占营运资金的比例 | 29.90% | 134.78% | 100.02% | 71.06% | 76.66% | 90.86% | 99.47% | 895.00% | 1464.03% | 60501.95% |
| 每股资本性支出(元) | 0.06 | 0.06 | 0.03 | 0.11 | (0.05) | 0.06 | 0.34 | 0.10 | 0.06 | 0.03 |
| 每股投入资本净额(元) | 10.69 | 9.30 | 7.87 | 6.91 | 6.62 | 6.92 | 6.56 | 6.61 | 6.56 | 6.69 |
| 每股经营活动产生的现金流(元) | 0.32 | 0.22 | 0.85 | 0.56 | 0.50 | 0.22 | 0.96 | 0.95 | 0.95 | 0.51 |
| 投资支出占收入之比 | 11.01% | 20.15% | 10.58% | 9.26% | 13.54% | 23.32% | 2.66% | 0.47% | 0.38% | 0.43% |
| 存货储存期(天) | 53.98 | 43.67 | 59.26 | 32.96 | 28.06 | 24.95 | 53.18 | 33.70 | 31.19 | 32.05 |
| 应付帐款付款期(天) | 76.91 | 69.04 | 79.86 | 52.27 | 42.82 | 41.64 | 68.61 | 74.78 | 64.68 | 67.08 |
| 应收帐款回收期(天) | 64.23 | 53.19 | 55.88 | 40.57 | 33.51 | 32.33 | 48.06 | 58.72 | 51.34 | 52.07 |
| 预付帐款占用期(天) | 3.38 | 30.40 | 18.62 | 2.98 | 1.77 | 1.91 | 3.90 | 1.30 | 1.85 | 1.48 |
| 预收帐款信用期(天) | 1.88 | 2.03 | 2.55 | 1.23 | 1.06 | 1.08 | 2.46 | 1.33 | 1.75 | 0.50 |
| 现金占总资产比例 | 35.39% | 20.11% | 22.50% | 20.42% | 23.20% | 21.98% | 22.13% | 14.40% | 15.60% | 14.72% |
| 存货占总资产比例 | 14.36% | 15.13% | 17.89% | 16.56% | 15.56% | 14.45% | 16.82% | 18.65% | 18.41% | 18.42% |
| 总资产同比增加比例 | 83.33% | 29.55% | 27.55% | 189.20% | 187.51% | 185.73% | 184.76% | 11.72% | 6.49% | 7.25% |
| 应付款项占总资产比例 | 20.46% | 23.92% | 24.11% | 26.26% | 23.74% | 24.11% | 21.70% | 41.39% | 38.18% | 38.55% |
| 应收款项占总资产比例 | 23.45% | 25.60% | 24.12% | 29.19% | 26.73% | 26.95% | 21.98% | 41.64% | 38.84% | 38.27% |
| 预收款项占总资产比例 | 0.69% | 0.98% | 1.10% | 0.89% | 0.85% | 0.90% | 1.12% | 0.95% | 1.32% | 0.37% |
| 预付款项占总资产比例 | 0.90% | 10.53% | 5.62% | 1.50% | 0.98% | 1.11% | 1.23% | 0.72% | 1.09% | 0.85% |
| 固定资产占总资产比例 | 7.70% | 11.08% | 12.95% | 12.91% | 13.45% | 14.57% | 16.32% | 9.07% | 9.64% | 9.77% |
| 无形资产占总资产比例 | 2.65% | 2.70% | 3.11% | 3.14% | 3.41% | 3.28% | 3.65% | 4.79% | 5.13% | 5.22% |
| 流动比例 | 1.79 | 1.27 | 1.30 | 1.32 | 1.32 | 1.30 | 1.29 | 1.03 | 1.02 | 1.00 |
| 速动比率 | 1.46 | 1.01 | 0.98 | 1.01 | 1.02 | 1.03 | 0.96 | 0.78 | 0.77 | 0.75 |
| 综合税率 | 1.68% | 2.76% | 1.33% | 1.25% | 1.28% | 1.22% | 1.75% | 0.59% | 0.55% | 0.65% |
| 实际所得税率 | 18.45% | 22.45% | 18.11% | 15.58% | 15.69% | 15.16% | 21.62% | 25.39% | 25.09% | 26.69% |
| 可持续增长率 | -4.02% | -0.82% | -2.37% | 23.44% | 12.51% | 52.31% | 63.10% | 1.76% | 数据为空 | 1.20% |
| 净利润现金含量 | 66.78% | 50.77% | 123.23% | 101.52% | 131.14% | 113.60% | 145.41% | 414.92% | 772.22% | 679.02% |
| 主营业务收入现金含量 | 90.37% | 86.47% | 93.82% | 89.82% | 91.38% | 83.83% | 97.79% | 92.69% | 93.09% | 100.82% |
| 经营性现金周期(天) | 134.02 | 134.18 | 140.13 | 83.96 | 69.29 | 66.12 | 114.06 | 104.23 | 93.63 | 95.04 |
| 单位收入需投入现金 | 0.92 | 0.90 | 0.90 | 0.89 | 0.89 | 0.89 | 0.89 | 0.94 | 0.94 | 0.95 |
| 单位收入产生的现金 | 0.03 | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.01 |
| 单位收入可用于增长的现金 | 0.02 | 0.01 | 0.04 | 0.03 | 0.05 | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 |
| 市值环比增长 | 16.17% | -10.49% | -2.28% | 36.45% | 6.64% | -8.73% | 数据为空 | 数据为空 | 数据为空 | 数据为空 |
| 主评级建议 | 中性 | 中性 | 中性 | 优异 强买 | 优异 强买 | 优异 强买 | 中性 | 数据为空 | 数据为空 | 数据为空 |
| 次评级(敏感性) | 回避 | 中性 | 回避 | 优 待定 | 优异 强买 | 优异 强买 | 优-待定 | 数据为空 | 数据为空 | 数据为空 |
| 上海医药 | 11Q2 | 11Q1 | 10Q4 | 10Q3 | 10Q2 | 10Q1 | 09Q4 | 09Q3 | 09Q2 | 09Q1 |
| 恒瑞医药 | 11Q2 | 11Q1 | 10Q4 | 10Q3 | 10Q2 | 10Q1 | 09Q4 | 09Q3 | 09Q2 | 09Q1 | 08Q4 | 08Q3 | 08Q2 | 08Q1 |
| 当季收盘价 | 29.97 | 45.86 | 59.56 | 48.79 | 39.07 | 39.21 | 52.5 | 41.82 | 34.91 | 39.87 | 38.51 | 35.12 | 34.9 | 42.6 |
| 赢利能力评分 | 95.49 | 96.54 | 98.15 | 100.00 | 100.00 | 98.22 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| 成长能力评分 | 50.81 | 61.71 | 71.24 | 88.39 | 91.31 | 75.76 | 41.85 | 64.57 | 54.86 | 72.38 | 86.02 | 98.27 | 93.83 | 95.00 |
| 估值情况评分 | 41.41 | 42.76 | 28.46 | 39.26 | 47.75 | 43.05 | 32.59 | 51.69 | 60.55 | 69.31 | 55.88 | 46.47 | 58.35 | 61.07 |
| 信用情况评分 | 85.70 | 86.15 | 84.84 | 85.65 | 86.38 | 87.55 | 85.43 | 86.60 | 87.38 | 87.29 | 86.08 | 88.04 | 89.27 | 91.40 |
| 综合情况评价 | 65.84 | 70.38 | 67.28 | 80.03 | 83.21 | 76.03 | 57.67 | 74.85 | 73.71 | 82.03 | 83.38 | 85.42 | 86.89 | 88.09 |
| 报表期每股收益(元) | 0.42 | 0.34 | 0.97 | 0.75 | 0.53 | 0.27 | 1.07 | 0.76 | 0.60 | 0.41 | 0.82 | 0.53 | 0.37 | 0.17 |
| 预估全年每股收益(调整) | 0.74 | 1.17 | 0.97 | 1.07 | 1.02 | 0.93 | 0.94 | 1.14 | 1.13 | 1.48 | 1.13 | 0.88 | 1.07 | 1.32 |
| 每股净资产(元) | 3.49 | 5.01 | 4.64 | 4.39 | 4.04 | 3.78 | 4.29 | 3.97 | 3.80 | 4.34 | 3.91 | 3.61 | 3.44 | 3.97 |
| 每股自由现金流(元) | 0.02 | (0.10) | 0.13 | 0.00 | 0.10 | 0.14 | 0.48 | 0.44 | 0.52 | 0.55 | 0.01 | 0.11 | 0.08 | 0.06 |
| 当季净利润 | 2.13 | 2.54 | 1.61 | 1.72 | 1.88 | 2.03 | 1.93 | 1.00 | 1.60 | 2.13 | 1.48 | 0.83 | 1.18 | 0.74 |
| 当季主营业务收入 | 10.48 | 11.19 | 9.30 | 9.45 | 9.27 | 9.42 | 8.17 | 7.82 | 7.18 | 7.12 | 6.05 | 5.90 | 5.99 | 5.98 |
| 预估全年净利润(调整) | 8.37 | 8.80 | 7.30 | 8.01 | 7.61 | 6.94 | 5.83 | 7.06 | 6.99 | 7.66 | 5.82 | 4.58 | 5.51 | 5.70 |
| 预估全年主营业务收入 | 43.40 | 44.46 | 37.44 | 38.54 | 39.62 | 40.12 | 30.29 | 29.60 | 28.55 | 28.45 | 23.93 | 25.25 | 26.07 | 29.18 |
| 市净率 | 8.59 | 9.16 | 12.85 | 11.11 | 9.68 | 10.39 | 12.23 | 10.53 | 9.20 | 9.20 | 9.84 | 9.73 | 10.14 | 10.74 |
| 市销率(折算为全年数据) | 7.79 | 7.76 | 11.95 | 9.51 | 7.37 | 7.30 | 10.78 | 8.79 | 7.60 | 7.26 | 8.34 | 7.21 | 6.93 | 6.30 |
| 市盈率(调整) | 40.23 | 39.05 | 61.11 | 45.67 | 38.25 | 42.06 | 55.94 | 36.75 | 30.99 | 26.92 | 34.21 | 39.70 | 32.76 | 32.24 |
| 市盈率(含债去息税) | 40.40 | 39.20 | 61.95 | 45.96 | 38.45 | 42.26 | 56.68 | 36.75 | 30.99 | 26.92 | 34.21 | 39.70 | 32.76 | 32.24 |
| PER(以当期ROE为增长标准) | 2.07 | 1.95 | 2.95 | 2.02 | 1.71 | 2.01 | 2.51 | 1.40 | 1.19 | 0.98 | 1.28 | 1.78 | 1.27 | 1.25 |
| PEG(以3年均净利增长为标准) | 3.02 | 2.56 | 1.67 | 1.12 | 0.99 | 1.21 | 1.15 | 0.65 | 0.56 | 0.45 | 0.63 | 0.96 | 0.64 | 0.60 |
| PEG(以3年均收入增长为标准) | 1.83 | 1.71 | 2.57 | 1.82 | 1.45 | 1.56 | 1.97 | 1.32 | 1.17 | 1.03 | 1.28 | 1.37 | 1.08 | 0.90 |
| 预估总资产报酬率(调整) | 18.98% | 21.02% | 18.75% | 22.07% | 22.04% | 21.04% | 19.43% | 25.79% | 26.84% | 30.49% | 25.83% | 21.41% | 26.93% | 28.58% |
| 预估投入资本报酬率(调整) | 21.81% | 24.10% | 21.64% | 25.00% | 26.86% | 26.54% | 22.84% | 29.61% | 30.67% | 35.45% | 29.84% | 26.13% | 32.77% | 36.32% |
| 预估股东权益报酬率(调整) | 19.52% | 20.10% | 20.98% | 22.70% | 22.53% | 21.02% | 22.56% | 26.18% | 26.07% | 27.40% | 26.66% | 22.32% | 25.76% | 25.83% |
| 自由现金流与营业收入之比 | 0.99% | -6.67% | 2.65% | 0.01% | 4.07% | 11.29% | 9.84% | 12.39% | 22.54% | 39.68% | 0.30% | 3.28% | 3.66% | 4.04% |
| 二级市场自由现金收益率-报表期 | 0.06% | -0.22% | 0.23% | 0.00% | 0.26% | 0.37% | 0.93% | 1.07% | 1.52% | 1.40% | 0.04% | 0.33% | 0.25% | 0.13% |
| 总收入同比增长率 | 15.90% | 18.75% | 23.61% | 27.25% | 30.81% | 32.45% | 26.60% | 23.73% | 19.35% | 18.89% | 22.09% | 28.85% | 33.03% | 48.91% |
| 净利润同比增长率 | 19.55% | 25.10% | 8.78% | 19.14% | 4.81% | -4.41% | 57.40% | 72.22% | 94.55% | 186.33% | 2.43% | 10.05% | 24.75% | 1.18% |
| 当季收入同比增长率 | 13.01% | 18.75% | 13.77% | 20.75% | 29.17% | 32.45% | 35.06% | 32.64% | 19.80% | 18.89% | 5.71% | 21.12% | 20.22% | 48.91% |
| 当季净利润同比增长率 | 13.54% | 25.10% | -16.60% | 72.79% | 17.04% | -4.41% | 30.00% | 20.43% | 36.54% | 186.33% | -9.20% | -13.57% | 46.30% | 1.18% |
| 当季净利润同比增长率(调整) | 8.33% | 20.48% | -6.27% | 56.29% | 45.68% | 19.20% | -31.53% | 24.86% | 7.67% | 31.59% | 211.81% | -1.79% | 69.80% | 81.74% |
| 非经常项占比 | 0.97% | 0.52% | -0.99% | -3.55% | -4.03% | -3.94% | 14.07% | 12.28% | 19.51% | 19.33% | -40.64% | -35.76% | -44.80% | -107.55% |
| 净利润率(还原) | 21.41% | 22.63% | 19.51% | 20.61% | 21.64% | 22.31% | 19.23% | 19.08% | 21.68% | 24.79% | 24.34% | 19.46% | 21.54% | 22.39% |
| 税前利润率(还原) | 27.11% | 28.71% | 23.17% | 25.42% | 26.19% | 26.55% | 22.68% | 22.85% | 25.76% | 28.93% | 26.83% | 26.73% | 28.52% | 30.42% |
| 主营业务利润率 | 81.72% | 81.21% | 82.33% | 82.98% | 83.31% | 83.35% | 81.21% | 82.52% | 82.39% | 82.04% | 81.67% | 81.28% | 80.00% | 82.68% |
| 当季净利润率(还原) | 20.10% | 22.63% | 16.17% | 18.57% | 20.97% | 22.31% | 19.63% | 14.35% | 18.59% | 24.79% | 38.73% | 15.24% | 20.69% | 22.39% |
| 当季税前利润率(还原) | 25.40% | 28.71% | 16.36% | 23.89% | 25.83% | 26.55% | 22.22% | 17.54% | 22.61% | 28.93% | 27.12% | 23.09% | 26.63% | 30.42% |
| 当季主营业务利润率 | 82.26% | 81.21% | 80.36% | 82.33% | 83.26% | 83.35% | 77.68% | 82.75% | 82.73% | 82.04% | 82.81% | 83.88% | 77.33% | 82.68% |
| 当季权益报酬率(调整) | 5.36% | 6.74% | 4.26% | 5.36% | 6.50% | 7.52% | 5.90% | 4.64% | 5.46% | 7.65% | 10.97% | 5.09% | 6.94% | 9.02% |
| 经营性现金流同比增长率 | -0.75% | -62.31% | -12.11% | -28.92% | -27.88% | -44.60% | 273.84% | 192.86% | 347.30% | 432.92% | -46.33% | -57.00% | -57.58% | -36.78% |
| 综合业务利润率 | 81.72% | 81.21% | 82.33% | 82.98% | 83.31% | 83.35% | 81.21% | 82.52% | 82.39% | 82.04% | 81.67% | 81.28% | 80.00% | 82.68% |
| 当季综合业务利润率 | 82.26% | 81.21% | 80.36% | 82.33% | 83.26% | 83.35% | 77.68% | 82.75% | 82.73% | 82.04% | 82.81% | 83.88% | 77.33% | 82.68% |
| 总市值 | 336.91 | 343.69 | 446.36 | 365.65 | 291.03 | 292.07 | 325.89 | 259.59 | 216.70 | 206.24 | 199.21 | 181.67 | 180.53 | 183.64 |
| 总市值含债调整 | 337.11 | 343.89 | 446.56 | 365.75 | 291.13 | 292.17 | 325.99 | 259.59 | 216.70 | 206.24 | 199.21 | 181.67 | 180.53 | 183.64 |
| 资本性支出(亿) | 2.58 | 1.43 | 2.87 | 2.70 | 2.05 | 0.74 | 1.41 | 1.07 | 0.68 | 0.44 | 1.10 | 0.71 | 0.43 | 0.37 |
| 资本支出与销售收入比 | 11.90% | 12.76% | 7.65% | 9.60% | 10.98% | 7.89% | 4.65% | 4.82% | 4.75% | 6.17% | 4.61% | 3.99% | 3.63% | 6.20% |
| 总市值中的现金比例 | 2.89% | 2.77% | 2.23% | 2.52% | 2.62% | 2.57% | 2.17% | 2.59% | 3.50% | 3.24% | 1.93% | 2.39% | 2.93% | 3.00% |
| 营业费用与收入之比 | 40.05% | 39.84% | 42.86% | 42.72% | 44.02% | 41.41% | 44.42% | 45.61% | 45.88% | 39.38% | 40.35% | 40.58% | 41.06% | 37.86% |
| 管理费用与收入之比 | 14.72% | 12.95% | 16.60% | 15.04% | 13.32% | 15.75% | 14.39% | 14.36% | 10.85% | 13.61% | 14.29% | 13.94% | 10.04% | 14.00% |
| 财务费用与收入之比 | -0.16% | -0.29% | -0.29% | -0.20% | -0.23% | -0.37% | -0.28% | -0.30% | -0.10% | 0.11% | 0.20% | 0.04% | 0.38% | 0.41% |
| 期间费用占收入比 | 54.60% | 52.49% | 59.16% | 57.56% | 57.11% | 56.79% | 58.53% | 59.67% | 56.63% | 53.11% | 54.84% | 54.55% | 51.48% | 52.26% |
| 当季期间费用占收入比 | 56.86% | 52.49% | 64.01% | 58.45% | 57.44% | 56.79% | 55.46% | 65.22% | 60.12% | 53.11% | 55.68% | 60.79% | 50.70% | 52.26% |
| 期间费用占收入比同比增长率 | -4.40% | -7.57% | 1.08% | -3.53% | 0.86% | 6.94% | 6.73% | 9.37% | 10.00% | 1.62% | -11.05% | -5.56% | -15.69% | -6.46% |
| 当季期间费用占收入比同比增长率 | -1.02% | -7.57% | 15.41% | -10.38% | -4.46% | 6.94% | -0.40% | 7.28% | 18.58% | 1.62% | -21.65% | 17.64% | -22.30% | -6.46% |
| 生息负债率 | 0.45% | 0.48% | 0.51% | 0.28% | 0.29% | 0.30% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 资产负债率 | 11.16% | 10.36% | 10.80% | 9.32% | 12.89% | 14.81% | 11.13% | 10.02% | 9.55% | 10.76% | 10.20% | 12.64% | 13.01% | 14.24% |
| 每股生息负债(元) | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 免息负债与净资产比 | 0.12 | 0.11 | 0.12 | 0.10 | 0.14 | 0.17 | 0.12 | 0.11 | 0.11 | 0.12 | 0.11 | 0.14 | 0.15 | 0.17 |
| 生息负债与净资产比 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 每股现金保有额(元) | 0.87 | 1.27 | 1.33 | 1.23 | 1.02 | 1.01 | 1.14 | 1.08 | 1.22 | 1.29 | 0.74 | 0.84 | 1.02 | 1.28 |
| 存货环比增长率 | 1.63% | 28.22% | 6.34% | -6.39% | 5.10% | -4.92% | 3.40% | 3.53% | 2.56% | -0.60% | 47.21% | -5.77% | -1.88% | 3.57% |
| 应收帐款环比增长率 | 0.54% | 1.75% | 5.61% | 5.35% | 10.02% | 11.12% | 17.79% | 12.55% | -1.84% | 7.23% | 7.41% | 6.98% | 5.45% | 18.29% |
| 存货同比增长率 | 29.71% | 34.14% | -0.53% | -3.27% | 6.98% | 4.39% | 9.13% | 55.36% | 41.41% | 35.29% | 40.98% | -6.25% | 19.46% | 14.64% |
| 应收帐款同比增长率 | 13.83% | 24.56% | 36.03% | 51.71% | 62.07% | 44.60% | 39.54% | 27.25% | 20.95% | 29.93% | 43.33% | 124.00% | 156.10% | 206.47% |
| 预收帐款同比增长率 | -100.00% | 数据为空 | -100.00% | 数据为空 | 数据为空 | 数据为空 | -21.93% | 数据为空 | 数据为空 | 数据为空 | 数据为空 | 数据为空 | 数据为空 | 数据为空 |
| 存货周转率 - 单期值 | 3.15 | 3.41 | 3.44 | 3.61 | 3.40 | 3.59 | 2.96 | 2.76 | 2.76 | 2.88 | 2.47 | 3.92 | 4.11 | 3.83 |
| 总资产周转率-单期值 | 0.98 | 1.06 | 0.96 | 1.06 | 1.15 | 1.22 | 1.01 | 1.08 | 1.10 | 1.13 | 1.06 | 1.18 | 1.27 | 1.46 |
| 净资产周转率-单期值 | 1.11 | 1.18 | 1.08 | 1.17 | 1.32 | 1.43 | 1.14 | 1.20 | 1.21 | 1.27 | 1.18 | 1.35 | 1.46 | 1.71 |
| 应收帐款周转率--单期值 | 4.27 | 4.40 | 3.77 | 4.10 | 4.44 | 4.94 | 4.15 | 4.77 | 5.18 | 5.07 | 4.57 | 5.18 | 5.72 | 6.76 |
| 流动资产周转率--单期值 | 1.29 | 1.41 | 1.29 | 1.46 | 1.61 | 1.75 | 1.44 | 1.47 | 1.52 | 1.70 | 1.57 | 1.68 | 1.74 | 1.97 |
| 固定资产周转率--单期值 | 5.89 | 6.14 | 5.19 | 7.44 | 8.32 | 8.49 | 6.30 | 6.30 | 6.25 | 6.26 | 5.18 | 5.76 | 5.84 | 6.37 |
| 股本同比变动率 | 50.91% | 0.61% | 20.73% | 20.73% | 20.00% | 44.00% | 20.00% | 20.00% | 20.00% | 20.00% | 20.00% | 20.00% | 20.00% | 0.00% |
| 税前利润同比增长率 | 24.94% | 33.22% | 10.19% | 23.40% | 7.46% | -1.92% | 66.10% | 48.43% | 72.49% | 141.79% | -8.10% | 11.14% | 36.14% | -6.77% |
| 每股营运资金(元) | 2.65 | 3.85 | 3.46 | 3.31 | 2.75 | 2.62 | 2.94 | 2.88 | 2.79 | 2.94 | 2.56 | 2.36 | 2.42 | 2.77 |
| 短期借款占营运资金的比例 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 每股资本性支出(元) | 0.23 | 0.19 | 0.38 | 0.36 | 0.28 | 0.10 | 0.23 | 0.17 | 0.11 | 0.08 | 0.21 | 0.14 | 0.08 | 0.09 |
| 每股投入资本净额(元) | 3.42 | 4.87 | 4.50 | 4.27 | 3.80 | 3.51 | 4.11 | 3.84 | 3.67 | 4.18 | 3.77 | 3.39 | 3.25 | 3.64 |
| 每股经营活动产生的现金流(元) | 0.25 | 0.09 | 0.51 | 0.36 | 0.38 | 0.24 | 0.71 | 0.61 | 0.63 | 0.63 | 0.23 | 0.25 | 0.17 | 0.14 |
| 投资支出占收入之比 | 13.40% | 15.44% | 8.63% | 9.60% | 10.98% | 7.89% | 9.10% | 6.77% | 4.81% | 6.18% | 10.87% | 11.91% | 7.43% | 7.65% |
| 存货储存期(天) | 114.12 | 105.65 | 104.75 | 99.78 | 105.98 | 100.28 | 121.72 | 130.59 | 130.21 | 125.04 | 145.76 | 91.77 | 87.70 | 93.89 |
| 应付帐款付款期(天) | 114.37 | 83.91 | 116.83 | 67.32 | 72.43 | 74.57 | 95.22 | 97.20 | 99.61 | 95.45 | 118.51 | 50.92 | 61.03 | 47.73 |
| 应收帐款回收期(天) | 84.32 | 81.86 | 95.53 | 87.87 | 81.13 | 72.83 | 86.81 | 75.41 | 69.46 | 71.03 | 78.76 | 69.48 | 62.90 | 53.29 |
| 预付帐款占用期(天) | 105.10 | 76.56 | 55.80 | 44.18 | 4.60 | 19.14 | 20.69 | 32.54 | 29.59 | 38.54 | 32.69 | 19.42 | 14.42 | 3.91 |
| 预收帐款信用期(天) | 数据为空 | 数据为空 | 数据为空 | 0.98 | 0.45 | 数据为空 | 0.52 | 数据为空 | 数据为空 | 数据为空 | 0.84 | 数据为空 | 数据为空 | 数据为空 |
| 现金占总资产比例 | 22.07% | 22.75% | 25.54% | 25.43% | 22.11% | 22.78% | 23.58% | 24.53% | 29.15% | 26.57% | 17.09% | 20.29% | 25.84% | 27.65% |
| 存货占总资产比例 | 5.20% | 5.40% | 4.52% | 4.57% | 5.13% | 5.10% | 5.91% | 6.25% | 6.35% | 6.42% | 7.20% | 5.16% | 5.72% | 5.98% |
| 总资产同比增加比例 | 27.82% | 26.85% | 29.90% | 32.42% | 32.49% | 31.34% | 33.03% | 28.18% | 27.31% | 26.08% | 11.95% | 17.79% | 24.18% | 25.87% |
| 应付款项占总资产比例 | 5.22% | 4.28% | 5.04% | 3.08% | 3.50% | 3.79% | 4.62% | 4.65% | 4.86% | 4.90% | 5.85% | 2.86% | 3.98% | 3.04% |
| 应收款项占总资产比例 | 26.95% | 28.25% | 29.84% | 30.34% | 30.27% | 28.77% | 28.50% | 26.48% | 24.74% | 26.13% | 27.17% | 26.68% | 26.04% | 25.35% |
| 预收款项占总资产比例 | 0.00% | 0.00% | 0.00% | 0.34% | 0.17% | 0.00% | 0.17% | 0.00% | 0.00% | 0.00% | 0.29% | 0.00% | 0.00% | 0.00% |
| 预付款项占总资产比例 | 4.79% | 3.91% | 2.41% | 2.02% | 0.22% | 0.97% | 1.00% | 1.56% | 1.44% | 1.98% | 1.61% | 1.09% | 0.94% | 0.25% |
| 固定资产占总资产比例 | 16.71% | 17.30% | 18.53% | 14.28% | 13.79% | 14.32% | 16.03% | 17.16% | 17.54% | 18.07% | 20.49% | 20.51% | 21.80% | 22.99% |
| 无形资产占总资产比例 | 1.17% | 1.24% | 1.34% | 3.10% | 3.18% | 1.52% | 1.68% | 1.46% | 1.54% | 1.61% | 1.30% | 1.38% | 1.45% | 1.50% |
| 流动比例 | 7.31 | 7.97 | 7.46 | 8.56 | 5.71 | 5.08 | 6.63 | 7.51 | 7.96 | 6.62 | 6.76 | 5.52 | 5.72 | 5.28 |
| 速动比率 | 6.83 | 7.42 | 7.02 | 8.05 | 5.30 | 4.73 | 6.09 | 6.88 | 7.29 | 6.03 | 6.05 | 5.12 | 5.28 | 4.85 |
| 综合税率 | 6.09% | 6.54% | 4.30% | 5.50% | 5.23% | 5.10% | 4.38% | 4.74% | 5.58% | 5.66% | 3.01% | 6.96% | 6.49% | 5.96% |
| 实际所得税率 | 16.45% | 17.53% | 12.18% | 16.15% | 14.65% | 13.69% | 11.19% | 12.61% | 12.93% | 11.62% | 7.32% | 25.31% | 23.04% | 25.23% |
| 可持续增长率 | 1.75% | 4.92% | -1.18% | 12.33% | 11.35% | 5.21% | -6.13% | 5.13% | 1.82% | 8.86% | 54.71% | -0.41% | 19.15% | 26.80% |
| 净利润现金含量 | 59.71% | 26.78% | 53.29% | 48.02% | 71.92% | 88.91% | 65.96% | 80.48% | 104.52% | 153.40% | 27.77% | 47.33% | 45.46% | 82.42% |
| 主营业务收入现金含量 | 89.56% | 85.21% | 89.00% | 86.86% | 85.77% | 82.22% | 87.12% | 90.66% | 99.78% | 108.60% | 91.51% | 87.41% | 86.65% | 84.97% |
| 经营性现金周期(天) | 208.70 | 192.45 | 194.62 | 178.30 | 158.46 | 152.93 | 173.66 | 154.77 | 136.60 | 128.61 | 166.00 | 131.63 | 114.21 | 92.34 |
| 单位收入需投入现金 | 数据为空 | 数据为空 | 数据为空 | 0.59 | 0.57 | 数据为空 | 0.60 | 数据为空 | 数据为空 | 数据为空 | 0.61 | 数据为空 | 数据为空 | 数据为空 |
| 单位收入产生的现金 | 0.24 | 0.25 | 0.22 | 0.23 | 0.24 | 0.25 | 0.21 | 0.21 | 0.23 | 0.27 | 0.27 | 0.23 | 0.25 | 0.28 |
| 单位收入可用于增长的现金 | 0.12 | 0.12 | 0.14 | 0.13 | 0.13 | 0.17 | 0.17 | 0.16 | 0.19 | 0.20 | 0.22 | 0.19 | 0.22 | 0.22 |
| 市值环比增长 | -1.97% | -23.00% | 22.07% | 25.64% | -0.36% | -10.38% | 25.54% | 19.79% | 5.07% | 3.53% | 9.65% | 0.63% | -1.69% | -26.23% |
| 主评级建议 | 中性 | 良 可关注 | 中性 | 优 买入 | 优 买入 | 良 可关注 | 中性 | 良 可关注 | 良 可关注 | 优 买入 | 优 买入 | 优 买入 | 优 买入 | 优异 强买 |
| 次评级(敏感性) | 中性 | 良 可关注 | 回避 | 良 可关注 | 优 买入 | 良 可关注 | 中性 | 良 可关注 | 中性 | 优 买入 | 良 可关注 | 中性 | 优 待定 | 优异 强买 |
| 恒瑞医药 | 11Q2 | 11Q1 | 10Q4 | 10Q3 | 10Q2 | 10Q1 | 09Q4 | 09Q3 | 09Q2 | 09Q1 | 08Q4 | 08Q3 | 08Q2 | 08Q1 |